FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1727448405> ?p ?o ?g. }

• W1727448405 endingPage "13" @default.
• W1727448405 startingPage "7" @default.
• W1727448405 abstract "Ischemia is accompanied by mitochondrial dysfunction, as assessed by measurements of mitochondrial respiratory activities in vitro. Following brief periods of ischemia, mitochondrial function is usually normalized during reperfusion. However, particularly after ischemia of longer duration, reperfusion may be accompanied by secondary mitochondrial failure. After short periods of ischemia this is observed in selectively vulnerable areas and, after intermediate to long periods of ischemia, in other areas as well. However, it has remained unsettled if the mitochondrial dysfunction is the result or the cause of cell death. Although it has been commonly assumed that such failure is secondary to cell injury by other mechanisms, recent results suggest that mitochondrial dysfunction may be the cause of cell death. Indirect evidence for this postulate is provided by experiments showing that cyclosporin A (CsA), when allowed to cross the blood-brain barrier, is a potent neuroprotectant. CsA is a virtually specific blocker of the mitochondrial permeability transition (MPT) pore, a voltage-gated channel allowing molecules and ions with a mass < 1500 Daltons to pass the inner mitochondrial membrane. Experiments on isolated cells in vitro demonstrate that cell calcium accumulation or oxidative stress triggers the assembly of an MPT pore, which leads to collapse of the mitochondrial membrane potential, to ATP hydrolysis, to enhanced production of reactive oxygen species (ROS), and to cell death. The beneficial effect of CsA could thus be related to its ability to block the MPT pore. Longer periods of ischemia, such as occurs after transient middle cerebral artery (MCA) occlusion, lead to pan-necrotic lesions (infarction). In the rat, recirculation following 2 h of MCA occlusion leads to partial normalization of the bioenergetic state but this is followed within 4-6 h by secondary bioenergetic failure. The latter seems unrelated to blockade of the microcirculation, but correlates to secondary mitochondrial failure. The brain damage incurred is ameliorated by the spin trap alpha-phenyl-N-butyl nitrone (PBN) and by the immunosuppressant FK506 even when given 1-3 h after the start of recirculation. The two drugs also prevent the secondary mitochondrial failure during early recirculation, suggesting that such failure is pathogenetically important. Probably, though, the mitochondrial dysfunction involves not only the assembly of an MPT pore but also other mechanisms. Since recirculation is associated with release of mitochondrial proteins it is not unlikely that such proteins, e.g. cytochrome c, trigger cascades of events leading to cell death.6." @default.
• W1727448405 created "2016-06-24" @default.
• W1727448405 creator A5047457026 @default.
• W1727448405 creator A5059402016 @default.
• W1727448405 creator A5063819703 @default.
• W1727448405 creator A5069872743 @default.
• W1727448405 creator A5083219599 @default.
• W1727448405 creator A5083796118 @default.
• W1727448405 creator A5086342334 @default.
• W1727448405 date "1999-01-01" @default.
• W1727448405 modified "2023-10-18" @default.
• W1727448405 title "Role and Mechanisms of Secondary Mitochondrial Failure" @default.
• W1727448405 cites W113889405 @default.
• W1727448405 cites W1503225378 @default.
• W1727448405 cites W1528505919 @default.
• W1727448405 cites W1533229430 @default.
• W1727448405 cites W1583699416 @default.
• W1727448405 cites W1829813323 @default.
• W1727448405 cites W1969004566 @default.
• W1727448405 cites W1969612832 @default.
• W1727448405 cites W1971141628 @default.
• W1727448405 cites W1971335269 @default.
• W1727448405 cites W1972681977 @default.
• W1727448405 cites W1974182326 @default.
• W1727448405 cites W1976467696 @default.
• W1727448405 cites W1979406476 @default.
• W1727448405 cites W1982892406 @default.
• W1727448405 cites W1984616391 @default.
• W1727448405 cites W1988881255 @default.
• W1727448405 cites W1994105347 @default.
• W1727448405 cites W1995653128 @default.
• W1727448405 cites W1996568613 @default.
• W1727448405 cites W2008757109 @default.
• W1727448405 cites W2009543520 @default.
• W1727448405 cites W2009604334 @default.
• W1727448405 cites W2009926364 @default.
• W1727448405 cites W2012763790 @default.
• W1727448405 cites W2015583712 @default.
• W1727448405 cites W2016871397 @default.
• W1727448405 cites W2020034315 @default.
• W1727448405 cites W2020622209 @default.
• W1727448405 cites W2022940264 @default.
• W1727448405 cites W2023826599 @default.
• W1727448405 cites W2024139423 @default.
• W1727448405 cites W2024434386 @default.
• W1727448405 cites W2025581014 @default.
• W1727448405 cites W2027608784 @default.
• W1727448405 cites W2029404346 @default.
• W1727448405 cites W2030454822 @default.
• W1727448405 cites W2031702150 @default.
• W1727448405 cites W2035838366 @default.
• W1727448405 cites W2045698094 @default.
• W1727448405 cites W2048517328 @default.
• W1727448405 cites W2049189117 @default.
• W1727448405 cites W2053828891 @default.
• W1727448405 cites W2054120161 @default.
• W1727448405 cites W2061144992 @default.
• W1727448405 cites W2063271495 @default.
• W1727448405 cites W2063385957 @default.
• W1727448405 cites W2063772445 @default.
• W1727448405 cites W2064570219 @default.
• W1727448405 cites W2074036818 @default.
• W1727448405 cites W2075874065 @default.
• W1727448405 cites W2076610743 @default.
• W1727448405 cites W2077921614 @default.
• W1727448405 cites W2079497446 @default.
• W1727448405 cites W2087823654 @default.
• W1727448405 cites W2088139307 @default.
• W1727448405 cites W2092786605 @default.
• W1727448405 cites W2104592058 @default.
• W1727448405 cites W2108131089 @default.
• W1727448405 cites W2110357545 @default.
• W1727448405 cites W2154346380 @default.
• W1727448405 cites W2255939110 @default.
• W1727448405 cites W2328817794 @default.
• W1727448405 cites W4211255027 @default.
• W1727448405 doi "https://doi.org/10.1007/978-3-7091-6391-7_2" @default.
• W1727448405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10494335" @default.
• W1727448405 hasPublicationYear "1999" @default.
• W1727448405 type Work @default.
• W1727448405 sameAs 1727448405 @default.
• W1727448405 citedByCount "48" @default.
• W1727448405 countsByYear W17274484052012 @default.
• W1727448405 countsByYear W17274484052013 @default.
• W1727448405 countsByYear W17274484052014 @default.
• W1727448405 countsByYear W17274484052015 @default.
• W1727448405 countsByYear W17274484052016 @default.
• W1727448405 countsByYear W17274484052017 @default.
• W1727448405 countsByYear W17274484052018 @default.
• W1727448405 countsByYear W17274484052019 @default.
• W1727448405 countsByYear W17274484052020 @default.
• W1727448405 countsByYear W17274484052021 @default.
• W1727448405 countsByYear W17274484052022 @default.
• W1727448405 countsByYear W17274484052023 @default.
• W1727448405 crossrefType "book-chapter" @default.
• W1727448405 hasAuthorship W1727448405A5047457026 @default.
• W1727448405 hasAuthorship W1727448405A5059402016 @default.
• W1727448405 hasAuthorship W1727448405A5063819703 @default.

• next